Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Delivery of soluble tumor necrosis factor receptor from in-situ forming PLGA implants: in-vivo.

× No keyword cloud information.

22 in total

1. Characterization of a polymeric PLGA-injectable implant delivery system for the controlled release of proteins.

Authors: R E Eliaz; J Kost
Journal: J Biomed Mater Res Date: 2000-06-05

2. LPS-induced sTNF-receptor release in vivo in a murine model. Investigation of the role of tumor necrosis factor, IL-1, leukemia inhibiting factor, and IFN-gamma.

Authors: M H Bemelmans; D J Gouma; W A Buurman
Journal: J Immunol Date: 1993-11-15 Impact factor: 5.422

3. Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors.

Authors: H Engelmann; D Novick; D Wallach
Journal: J Biol Chem Date: 1990-01-25 Impact factor: 5.157

4. Long-term protection against the effects of tumour necrosis factor by controlled delivery of the soluble p55 TNF receptor.

Authors: R Eliaz; D Wallach; J Kost
Journal: Cytokine Date: 1996-06 Impact factor: 3.861

5. Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients.

Authors: D Aderka; H Englemann; V Hornik; Y Skornick; Y Levo; D Wallach; G Kushtai
Journal: Cancer Res Date: 1991-10-15 Impact factor: 12.701

6. Elevated serum levels of soluble tumour necrosis factor receptors (sTNF-R) in patients with HIV infection.

Authors: A Kalinkovich; H Engelmann; N Harpaz; R Burstein; V Barak; I Kalickman; D Wallach; Z Bentwich
Journal: Clin Exp Immunol Date: 1992-09 Impact factor: 4.330

7. Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases.

Authors: A P Cope; D Aderka; M Doherty; H Engelmann; D Gibbons; A C Jones; F M Brennan; R N Maini; D Wallach; M Feldmann
Journal: Arthritis Rheum Date: 1992-10

8. Isolation and characterization of a tumor necrosis factor binding protein from urine.

Authors: I Olsson; M Lantz; E Nilsson; C Peetre; H Thysell; A Grubb; G Adolf
Journal: Eur J Haematol Date: 1989-03 Impact factor: 2.997

9. Evaluation of local toxicity after repeated intranasal vaccination of guinea-pigs.

Authors: S Gizurarson; G Georgsson; H Aggerbeck; H Thorarinsdóttir; I Heron
Journal: Toxicology Date: 1996-01-22 Impact factor: 4.221

10. Tumors secreting human TNF/cachectin induce cachexia in mice.

Authors: A Oliff; D Defeo-Jones; M Boyer; D Martinez; D Kiefer; G Vuocolo; A Wolfe; S H Socher
Journal: Cell Date: 1987-08-14 Impact factor: 41.582

10 in total

1. Preparation of PLGA microparticles by an emulsion-extraction process using glycofurol as polymer solvent.

Authors: Anne Aubert-Pouëssel; Marie-Claire Venier-Julienne; Patrick Saulnier; Michelle Sergent; Jean-Pierre Benoît
Journal: Pharm Res Date: 2004-12 Impact factor: 4.200

Review 2. Long-acting injectable hormonal dosage forms for contraception.

Authors: Linfeng Wu; Dileep R Janagam; Timothy D Mandrell; James R Johnson; Tao L Lowe
Journal: Pharm Res Date: 2015-04-22 Impact factor: 4.200

3. Injectable Sustained-Release Depots of PLGA Microspheres for Insoluble Drugs Prepared by hot-Melt Extrusion.

Authors: Yuting Guo; Yunning Yang; Luying He; Rong Sun; Chenguang Pu; Bin Xie; Haibing He; Yu Zhang; Tian Yin; Yanjiao Wang; Xing Tang
Journal: Pharm Res Date: 2017-07-24 Impact factor: 4.200

4. Improved small molecule drug release from in situ forming poly(lactic-co-glycolic acid) scaffolds incorporating poly(β-amino ester) and hydroxyapatite microparticles.

Authors: Paul D Fisher; Pablo Palomino; Todd A Milbrandt; J Zach Hilt; David A Puleo
Journal: J Biomater Sci Polym Ed Date: 2014-06-06 Impact factor: 3.517

5. Sustained delivery of dibutyryl cyclic adenosine monophosphate to the transected spinal cord via oligo [(polyethylene glycol) fumarate] hydrogels.

Authors: Gemma E Rooney; Andrew M Knight; Nicolas N Madigan; Louann Gross; Bingkun Chen; Catalina Vallejo Giraldo; Seungmae Seo; Jarred J Nesbitt; Mahrokh Dadsetan; Michael J Yaszemski; Anthony J Windebank
Journal: Tissue Eng Part A Date: 2011-02-05 Impact factor: 3.845

6. Effect of cargo properties on in situ forming implant behavior determined by noninvasive ultrasound imaging.

Authors: Luis Solorio; Alexander M Olear; Haoyan Zhou; Ashlei C Beiswenger; Agata A Exner
Journal: Drug Deliv Transl Res Date: 2012-02-01 Impact factor: 4.617

Review 7. Silk constructs for delivery of musculoskeletal therapeutics.

Authors: Lorenz Meinel; David L Kaplan
Journal: Adv Drug Deliv Rev Date: 2012-04-13 Impact factor: 15.470

8. Relationship between scaffold channel diameter and number of regenerating axons in the transected rat spinal cord.

Authors: Aaron J Krych; Gemma E Rooney; Bingkun Chen; Thomas C Schermerhorn; Syed Ameenuddin; LouAnn Gross; Michael J Moore; Bradford L Currier; Robert J Spinner; Jonathan A Friedman; Michael J Yaszemski; Anthony J Windebank
Journal: Acta Biomater Date: 2009-03-27 Impact factor: 8.947

9. Application of hydroxyapatite nanoparticles in development of an enhanced formulation for delivering sustained release of triamcinolone acetonide.

Authors: Saeid Koocheki; Sayed Siavash Madaeni; Parisa Niroomandi
Journal: Int J Nanomedicine Date: 2011-04-19

10. Noninvasive characterization of the effect of varying PLGA molecular weight blends on in situ forming implant behavior using ultrasound imaging.

Authors: Luis Solorio; Alexander M Olear; Jesse I Hamilton; Ravi B Patel; Ashlei C Beiswenger; Jon E Wallace; Haoyan Zhou; Agata A Exner
Journal: Theranostics Date: 2012-11-08 Impact factor: 11.556

10 in total